SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
月月鸟
Lv3
370 积分
2023-09-08 加入
最近求助
最近应助
互助留言
Novel Glucagon-Like Peptide-1 (GLP-1) Analog (Val8)GLP-1 Results in Significant Improvements of Glucose Tolerance and Pancreatic β-Cell Function after 3-Week Daily Administration in Obese Diabetic (ob/ob) Mice
12天前
已完结
GLP-1 Val8: A Biased GLP-1R Agonist with Altered Binding Kinetics and Impaired Release of Pancreatic Hormones in Rats
13天前
已关闭
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
1个月前
已完结
What is the evidence regarding the safety of new obesity pharmacotherapies
1个月前
已完结
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
1个月前
已完结
Animal studies on glucagon-like peptide-1 receptor agonists and related polyagonists in nonalcoholic fatty liver disease
1个月前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
1个月前
已完结
What is the evidence regarding the safety of new obesity pharmacotherapies
1个月前
已完结
An updated patent review of GLP-1 receptor agonists (2020-present)
1个月前
已完结
Peptide Polyagonists for the Treatment of Nonalcoholic Fatty Liver Disease
1个月前
已完结
没有进行任何应助
搞错文章【积分已退回】
13天前
速度真快
1个月前
速度真快
1个月前
点赞
1个月前
速度真快
2个月前
帮大忙了
2个月前
感谢
2个月前
速度真快
4个月前
感谢
4个月前
速度真快
6个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论